Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2017

Sep 15, 2017

34999_dirs_2017-09-15_2184bf4f-0049-4d82-b47d-fefcfa533f21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2017-09-14

Reporting Person: CUDDIHY ROBERT V JR (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-14 Common Stock, par value $0.005 M 200000 $1.00 Acquired 331324 Direct
2017-09-14 Common Stock, par value $0.005 M 120000 $1.65 Acquired 451324 Direct
2017-09-14 Common Stock, par value $0.005 M 40000 $1.39 Acquired 491324 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-14 Employee Stock Option (right to buy) $1.00 M 200000 Disposed 2017-12-15 Common Stock (200000) Direct
2017-09-14 Employee Stock Option (right to buy) $1.65 M 120000 Disposed 2019-12-18 Common Stock (120000) Direct
2017-09-14 Employee Stock Option (right to buy) $1.39 M 40000 Disposed 2021-12-18 Common Stock (40000) Direct